PPARG Polymorphisms Are Associated with Unexplained Mild Vision Loss in Patients with Type 2 Diabetes Mellitus

Prevalence and clinical characteristics of dry eye disease in community-based type 2 diabetic patients: the Beixinjing eye study

(2018) Xinrong Zou et al.   BMC Ophthalmology

Interaction between peroxisome proliferator-activated receptor gamma polymorphism and obesity on type 2 diabetes in a Chinese Han population

(2017) Xiaohui Lv et al.   Diabetology & Metabolic Syndrome

Cataract was the principle cause of visual impairment and blindness in Shanghai residents with type 2 diabetes

(2015) Xian Xu et al.   ACTA OPHTHALMOLOGICA

Association and Interaction ofPPARα,δ,andγGene Polymorphisms with Low-Density Lipoprotein-Cholesterol in a Chinese Han Population

(2015) Wei Fan et al.   Genetic Testing and Molecular Biomarkers

Prevention of type 2 diabetes among women with prior gestational diabetes mellitus

(2015) Moshe Hod et al.   INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS

The gene polymorphisms of UCP1 but not PPAR γ and TCF7L2 are associated with diabetic retinopathy in Chinese type 2 diabetes mellitus cases

(2014) Yue Zhang et al.   ACTA OPHTHALMOLOGICA

Peroxisome Proliferator–Activated Receptor α Protects Capillary Pericytes in the Retina

(2014) Lexi Ding et al.   AMERICAN JOURNAL OF PATHOLOGY

Pioglitazone Normalizes Insulin Signaling in the Diabetic Rat Retina through Reduction in Tumor Necrosis Factor α and Suppressor of Cytokine Signaling 3

(2014) Youde Jiang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Inhibition of Oxygen-Induced Ischemic Retinal Neovascularization with Adenoviral 15-Lipoxygenase-1 Gene Transfer via Up-Regulation of PPAR-γ and Down-Regulation of VEGFR-2 Expression

(2014) Zhi Li et al.   PLoS One

Real-Time Support of Pediatric Diabetes Self-Care by a Transport Team

(2013) Brandi E. Franklin et al.   DIABETES CARE

Association of Peroxisome Proliferator-Activated Receptor ^|^alpha;/^|^delta;/^|^gamma; With Obesity, and Gene^|^ndash;Gene Interaction, in the Chinese Han Population

(2013) Wenshu Luo et al.   JOURNAL OF EPIDEMIOLOGY

Inflammation, Haemostatic Disturbance, and Obesity: Possible Link to Pathogenesis of Diabetic Retinopathy in Type 2 Diabetes

(2013) Martina Tomić et al.   MEDIATORS OF INFLAMMATION

Dietary wolfberry upregulates carotenoid metabolic genes and enhances mitochondrial biogenesis in the retina of db/db diabetic mice

(2013) Huifeng Yu et al.   MOLECULAR NUTRITION & FOOD RESEARCH

DNA Sequence Variants in PPARGC1A, a Gene Encoding a Coactivator of the ω-3 LCPUFA Sensing PPAR-RXR Transcription Complex, Are Associated with NV AMD and AMD-Associated Loci in Genes of Complement and VEGF Signaling Pathways

(2013) John Paul SanGiovanni et al.   PLoS One

The Role of Peroxisome Proliferator-Activated Receptor and Effects of Its Agonist, Pioglitazone, on a Rat Model of Optic Nerve Crush: PPARγ in Retinal Neuroprotection

(2013) Juming Zhu et al.   PLoS One

The emerging challenge in diabetes: The “metabolic memory”

(2012) Antonio Ceriello   VASCULAR PHARMACOLOGY

The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives

(2011) Lei Chen et al.   Nature Reviews Endocrinology

The Association Between the Peroxisome Proliferator-Activated Receptor-γ2 (PPARG2) Pro12Ala Gene Variant and Type 2 Diabetes Mellitus: A HuGE Review and Meta-Analysis

(2010) Hebe N. Gouda et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Improvement of Retinal Vascular Injury in Diabetic Rats by Statins Is Associated With the Inhibition of Mitochondrial Reactive Oxygen Species Pathway Mediated by Peroxisome Proliferator-Activated Receptor   Coactivator 1 

(2010) Z. Zheng et al.   DIABETES

Pparg-P465L Mutation Worsens Hyperglycemia in Ins2-Akita Female Mice via Adipose-Specific Insulin Resistance and Storage Dysfunction

(2010) A. A. Pendse et al.   DIABETES

PPAR-, Microglial Cells, and Ocular Inflammation: New Venues for Potential Therapeutic Approaches

(2008) Fiorella Malchiodi-Albedi et al.   PPAR Research